齐齐哈尔医学院学报
齊齊哈爾醫學院學報
제제합이의학원학보
JOURNAL OF QIQIHAR MEDICAL COLLEGE
2015年
16期
2347-2349
,共3页
益气养阴方%化疗%中晚期非小细胞肺癌
益氣養陰方%化療%中晚期非小細胞肺癌
익기양음방%화료%중만기비소세포폐암
Yiqiyangyin prescription%Chemotherapy%Advanced non-small cell lung cancer
目的:探讨益气养阴方联合化疗在中晚期非小细胞肺癌治疗中的应用效果。方法本组83例患者随机分为观察组(n=43)和对照组(n=40)。观察组采用益气养阴方联合化疗治疗,对照组单用化疗治疗。结果观察组总有效率(53.49%)显著高于对照组(30.00%),且具有显著性意义(P<0.05);观察组CD3+、CD4+、CD4+/CD8+显著高于对照组, CD8+显著低于对照组,且均具有显著性意义( P<0.05);观察组治疗后KPS评分提高患者显著多于对照组,且具有显著性意义(P<0.05);观察组血清CEA和CA125治疗后显著低于对照组,且均具有显著性意义( P<0.05)。结论益气养阴方联合化疗在中晚期非小细胞肺癌治疗中的应用效果显著。
目的:探討益氣養陰方聯閤化療在中晚期非小細胞肺癌治療中的應用效果。方法本組83例患者隨機分為觀察組(n=43)和對照組(n=40)。觀察組採用益氣養陰方聯閤化療治療,對照組單用化療治療。結果觀察組總有效率(53.49%)顯著高于對照組(30.00%),且具有顯著性意義(P<0.05);觀察組CD3+、CD4+、CD4+/CD8+顯著高于對照組, CD8+顯著低于對照組,且均具有顯著性意義( P<0.05);觀察組治療後KPS評分提高患者顯著多于對照組,且具有顯著性意義(P<0.05);觀察組血清CEA和CA125治療後顯著低于對照組,且均具有顯著性意義( P<0.05)。結論益氣養陰方聯閤化療在中晚期非小細胞肺癌治療中的應用效果顯著。
목적:탐토익기양음방연합화료재중만기비소세포폐암치료중적응용효과。방법본조83례환자수궤분위관찰조(n=43)화대조조(n=40)。관찰조채용익기양음방연합화료치료,대조조단용화료치료。결과관찰조총유효솔(53.49%)현저고우대조조(30.00%),차구유현저성의의(P<0.05);관찰조CD3+、CD4+、CD4+/CD8+현저고우대조조, CD8+현저저우대조조,차균구유현저성의의( P<0.05);관찰조치료후KPS평분제고환자현저다우대조조,차구유현저성의의(P<0.05);관찰조혈청CEA화CA125치료후현저저우대조조,차균구유현저성의의( P<0.05)。결론익기양음방연합화료재중만기비소세포폐암치료중적응용효과현저。
Objective To investigate the application effect of Yiqiyangyin prescription combined with chemotherapy in treating advanced non-small cell lung cancer .Methods Total of 83 patients were randomly divided into observation group (n=43) and control group (n=40).Patients in observation group were treated with Yiqiyangyin prescription combined chemotherapy , while the patients in control group were treated with chemotherapy alone.Results The overall response rate of observation group (53.49%) was significantly higher than that of control group (30.00%), the difference was statistically significant (P<0.05).The concentration of CD3 +and CD4 +and the ratio of CD4+/CD8+of observation group significantly higher than that of control group, however, the concentration of CD8+of observation group was significantly lower than the control group , the differences were statistically significant ( P <0.05).After the treatment, KPS increasing patients in observation group significant excess than the control group , and serum CEA and CA 125 of the observation significantly lower than the control group (P <0.05).Conclusions Yiqiyangyin prescription combined with chemotherapy has significant effect in treating advanced non-small cell lung cancer .